CAS RN 152459-95-5
CAS RN 152459-95-5
Imatinib, Mikromol™
Découvrir Mikromol - Votre source de confiance pour des normes de référence pharmaceutiques de haute qualité. Soutenir une analyse précise et conforme avec ISO Matériaux accrédités ISO 17034 conçus pour garantir la confiance dans chaque résultat.
Imatinib, TRC
CAS: 152459-95-5 Formule moléculaire: C29 H31 N7 O Poids moléculaire (g/mol): 493.6 Synonyme: Benzamide, 4-[(4-methyl-1-piperazinyl)methyl]-N-[4-methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]phenyl]-,4-[(4-Methyl-1-piperazinyl)methyl]-N-[4-methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]phenyl]benzamide,4-(4-Methylpiperazin-1-ylmethyl)-N-[4-methyl-3-[[4-(pyridin-3-yl)pyrimidin-2-yl]amino]phenyl]benzamide,CGP 57148,Genfatinib,Imatinib Nom IUPAC: 4-[(4-methylpiperazin-1-yl)methyl]-N-[4-methyl-3-[(4-pyridin-3-ylpyrimidin-2-yl)amino]phenyl]benzamide SMILES: CN1CCN(Cc2ccc(cc2)C(=O)Nc3ccc(C)c(Nc4nccc(n4)c5cccnc5)c3)CC1
Imatinib, MedChemExpress
MedChemExpress Imatinib (STI571) is an orally bioavailable tyrosine kinases inhibitor that selectively inhibits BCR/ABL, v-Abl, PDGFR and c-kit kinase activity. Imatinib (STI571) works by binding close to the ATP binding site, locking it in a closed or self-inhibited conformation, therefore inhibiting the enzyme activity of the protein semicompetitively. Imatinib also is an inhibitor of SARS-CoV and MERS-CoV.